This project proposes to utilize a transgenic animal model of virus induced IDDM (RIP-LCMV) to study the pathogenesis and test novel therapeutic approaches for autoimmune diabetes. In previous studies, I has developed and characterized an interesting model of virus-induced diabetes in which an LCMV-derived viral protein (NP or GP) is placed under the regulation of an insulin promoter and this construct is incorporated into the mouse germline as a transgene. This transgenic animal will not develop IDDM; however, if it is infected with LCMV, then diabetes is induced in a rapid fashion (14 to 21 days). Further, I have demonstrated that if this same LCMV protein is simultaneously expressed in the thymus, then disease onset is significantly delayed (up to as long as 200 days, depending on the strain of mouse and H-2 haplotype). In addition, the delayed onset form of IDDM is mediated by CD4+ T helpers together with low affinity CD8+ T cells, whereas the acute version is mediated by high affinity CD8+ T cells. I propose to utilize this model system to study several interesting features of IDDM pathogenesis. There are four specific aims: 1. To determine the regulatory role of cytokines in autoimmune diabetes by assessing cytokine profiles during pathogenesis and using targeted short-term application of anti-cytokine antibodies to modulate IDDM. Th1 and Th2 cytokine profiles of lymphocytes infiltrating islets will be assessed at various times in both the fast and slow IDDM model. This information will be used to design targeted short-time application of anti-cytokine antibodies during the pathogenesis of IDDM to attempt to modify the outcome of the autoimmune process and minimize side effects. 2. To assess the efficacy of therapy in the slow-onset IDDM by oral tolerance induction to insulin and insulin analogs. These experiments will test the hypothesis that oral tolerance to insulin prevents IDDM via a """"""""bystander"""""""" effect of Th2 induced cytokines. 3. To determine the mechanism of beta-cell destruction by anti-self CTL in fast-onset and slow-onset IDDM by assessing the role of perforin and affinity of the CTL. These experiments will utilize double transgenic RIP-LCMV/perforin knockout mice to assess the effect of perforin and transfer experiments to assess the importance of affinity. 4. To assess the prevention of slow-onset and fast-onset IDDM by specific tolerization of anti-self CTL by the use of DNA vaccination. This will be assessed using plasmids expressing LCMV proteins and various injection routes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DK051091-04
Application #
2905850
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Akolkar, Beena
Project Start
1996-06-01
Project End
2001-05-31
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Bresson, Damien; Fradkin, Matthew; Manenkova, Yulia et al. (2010) Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes. Mol Ther 18:307-16
Horwitz, Marshall S; Efrat, Shimon; Christen, Urs et al. (2009) Adenovirus E3 MHC inhibitory genes but not TNF/Fas apoptotic inhibitory genes expressed in beta cells prevent autoimmune diabetes. Proc Natl Acad Sci U S A 106:19450-4
Ejrnaes, Mette; Videbaek, Nicoline; Christen, Urs et al. (2005) Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. J Immunol 174:2746-55
Christen, Urs; Darwiche, Rima; Thomas, Helen E et al. (2004) Virally induced inflammation triggers fratricide of Fas-ligand-expressing beta-cells. Diabetes 53:591-6
Christen, Urs; Benke, Dirk; Wolfe, Tom et al. (2004) Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest 113:74-84
Petersen, J S; Bregenholt, S; Apostolopolous, V et al. (2003) Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Clin Exp Immunol 134:38-45
von Herrath, Matthias G; Bot, Adrian (2003) Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms. Trends Immunol 24:289-93
Bot, A; Rodrigo, E; Wolfe, T et al. (2003) Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens. J Virol 77:5794-800
Christen, Urs; McGavern, Dorian B; Luster, Andrew D et al. (2003) Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171:6838-45
Asseman, C; von Herrath, M (2002) About CD4pos CD25pos regulatory cells. Autoimmun Rev 1:190-7

Showing the most recent 10 out of 21 publications